that these measures alone miss components of a patient's global health. Ideally, PROMs can supplement these traditional clinical measures to ensure that care is patient centered. 9 At the University of Utah, SSc is a disease seen in the Chronic Disease Clinic. This specialized clinic offers coordinated care between a rheumatologist, pulmonologist, and/or gastroenterologist and is supported by a team that includes advanced care practitioners, a pharmacist, a nurse specialist, a medical assistant, and a social worker. The team is organized to implement a subspecialist care plan that is both immediate and multiorgan system based and is designed to be patient centered to reduce the burden of multiple visits and testing. Patients are offered the opportunity to meet with all providers or a limited number based on their questions and needs, and all care is coordinated with necessary studies for the same day.
As part of our goal to serve patients in ways that are most advantageous to them, we implemented an optional personal health assessment. This tool is called My Evaluation (mEVAL) and included a current health visual analog scale (VAS), PROMIS Bank v1.0 depression, and PROMIS Bank v1.2 physical function. The PROMIS item bank PROMIS items have been reported to function similarly whether administered via paper or tablet, with similar user satisfaction. 10 We sought to understand if depression and physical function PROMs correlate with more diseaseseverity measures used in routine clinical practice in order to determine whether this tool could improve provider identification of care needs. Both mEVAL PROM results and SSc diseaseseverity measures were examined in order to inform the optimal use resources for SSc patient engagement. In particular, the administration of mEVAL in this chronic disease clinic was used to identify which patients would benefit from additional mental health services. We hypothesized that patients who were considered by the health care system to have the highest endstage disease burden would have the highest depression and lowest physical function scores.
METHODS

Patient Population
Systemic sclerosis patients who were seen in the University Chronic Disease Clinic were offered an mEVAL assessment while they were waiting to see the physician(s) for SSc care visits. The mEVAL is administered on a tablet computer and takes approximately 15 minutes for SSc patients to complete. Patients with hand contractures were provided a stylus to use. Each patient was assessed by 1 or more physicians for skin, musculoskeletal. and cardiopulmonary disease severity at the time of evaluation. Skin severity was determined by digital ulceration or diffuse skin distribution of skin thickening; musculoskeletal severity was presence or absence of arthritis, joint contracture, or myositis; and cardiopulmonary severity was determined by presence or absence of pulmonary arterial hypertension or interstitial lung disease and by pulmonary function testing. 
PROMIS Instruments
We used the computer adaptive test versions of PROMIS to assess depression (v1.0) and physical function (v1.2).
3 Each PROMIS question has 5 response options. Because the instrument is computer adaptive, subsequent questions are decided by a computer algorithm based on the previous response of the patient. This eliminates irrelevant questions and allows for a more precise score in a shorter amount of time. Typically, patients receive between 4 and 8 questions. PROMIS raw scores are transformed into T scores with an average score of 50 and an SD of 10. In all PROMIS domains, a higher T score represents more of the concept being measured. For negatively worded concepts such as depression, a T score of 60 is 1 SD worse than average; for positively worded concepts such as physical function, a T score of 60 is 1 SD better than average.
The depression item bank measures symptoms over the past 7 days and assesses self-reported negative mood (guilt and/or sadness), views of self (worthlessness and/or self-criticism), and social cognition (loneliness and/or interpersonal alienation), as well as decreased positive affect and engagement (loss of interest, meaning, and purpose). Important to the SSc patients, somatic symptoms (such as changes in appetite and sleeping patterns) are not included, which eliminates consideration of these items' confounding effects when assessing patients with comorbid physical conditions.
The physical function item bank measures self-assessed capability rather than actual performance of physical activities. This includes the functioning of one's upper extremities (dexterity), lower extremities (mobility or walking), and central regions (neck or back), as well as instrumental activities of daily living, such as running errands.
Visual Analog Scale
When responding to the VAS item, respondents specify their level of agreement to a statement of general health by indicating a position along a continuous line between 2 end points from 0 to 1.
RESULTS
During the first 6-month period of implementation period of mEVAL into the Chronic Disease Clinic, 491 unique SSc patients were seen at the University of Utah, and 234 received routine care in the Chronic Disease Clinic. Of these 234 patients, 137 patients completed the VAS and PROMIS physical function; 133 completed the PROMIS depression scales. Reasons for not completing the assessment in its entirety were not captured; however, there were no significant differences seen in age, sex, or presence of SSc-related symptoms in these noncompleters. The age range of these SSc patients completing the assessment is shown in Figure 1 . This population was mostly female and had limited skin involvement. Other clinical features of these 137 patients are reported in Table 1 . Of these 137 patients, 43 patients would be considered by physical examination and ancillary pulmonary studies to have no evidence of end-organ damage or disease activity, and 19 patients had insufficient ancillary study information to determine disease presence. The mEVAL results are reported in Table 2 . No patient considered themselves completely healthy on the VAS, with a mean of 0.51 reported. In the SSc population overall, the mean physical function was 41.26, approximately 1 SD below the US general population mean, and the mean depression score was 53.06, approximately in line with the US general population mean. In the SSc patient population, neither the physical function nor depression PROM was significantly elevated compared with the US population. For the patients who had no physical examination damage or activity indices, the mean physical function was 43.2, and mean depression was 50.9, which was not significantly different from those of the SSc patients with symptoms (52.9 and 51.7, respectively; P = 0.79 for both). There was no collinearity of physical function and depression in the patients who completed both assessments (Fig. 2) .
CONCLUSIONS
The implementation of patient-reported outcomes in routine SSc care highlights that self-report of general health, physical function, and depression provides an understanding of health that is distinct from the traditional measures of disease activity and damage for SSc and may be discordant. In this study, SSc patients with disease measured by traditional damage or activity indices had similar levels of perceived decreased physical function and depression to those of SSc patients with no disease-related complications. This highlights that there is a perceived burden simply associated with a diagnosis of a chronic disease regardless of severity. Knowledge of this decrease in quality of life may suggest targets for interventions earlier in a disease course. This may ultimately impact disease course as disease progresses or patient's sense of well-being while managing a chronic disease. In addition, bringing mental health and social work resources may restore function in patients who might otherwise be overwhelmed by the prospect of a lifelong chronic disease.
Limitations of this report include the relatively low rate of completion of the mEVAL measures and the single-site, specialty nature of the practice. While all patients are enrolled in an institutional review board-approved registry, because of the coordination of clinical care, patients may have not have seen the rheumatologist at the care visit when the patient-reported outcomes were administered; thus, items such as Medsger severity index or modified Rodnan skin scores were not available at the time of care. Future work should focus on barriers and facilitators to questionnaire completion and on the value of the questionnaires to the patient's overall care. In addition, the lack of difference in mean physical function and mean depression between patients with and without damage should be further explored after educational interventions. We did not adequately capture if a patient understood his/her prognosis. Of note, 46 patients opted out of completing the PROMIS depression bank, indicating that while mental health needs may be underestimated, this assessment was generally acceptable to patients in this practice. In addition, patients were provided the mEVAL while waiting for the physician; thus, time constraints may have influenced completion rate. Nonetheless, mEVAL was effective in identifying patients with depression (with a score >60) who would benefit from social work intervention to explore the etiology of these perceived reductions in general health and physical function and provide additional treatment of depression.
Overall, the assessment of depression and physical function was feasible in this specialty population. The use of PROMs resulted in additional intervention directed toward reducing perceived disease burden. Future work should follow up patients longitudinally to identify the impact of disease course and intervention over time and determine the optimum time to provide the instrument to the patient. Continued study is necessary to understand the overall benefit to using PROM in the clinical setting to improve health outcomes.
